Stay updated on Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- Check3 days agoChange DetectedThe bottom of the page now shows Revision: v3.5.2, replacing the previous v3.5.0. This appears to be a minor version update with no impact on study details.SummaryDifference0.0%

- Check10 days agoChange DetectedThe Veneto, Italy site entry changed from Padua (35128) to Padova (35128) in the location list.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedTwo Italian study locations were updated from Napoli, Campania, Italy to Naples, Campania, Italy (postal codes 80131 and 80138); revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 to reflect the latest software version.SummaryDifference0.0%

- Check60 days agoChange DetectedNew study sites have been added in Budapest, Hungary (1044) and Lviv, Ukraine (79029). Some previous locations (Budapest 1138 and Lviv 79007) were removed, and Neurofocus LLC was added.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed the operating-status notice about funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.